Adelene Q. Perkins, EVP and Chief Business Officer at INFINITY PHARMACEUTICALS, INC. (INFI), bought 776 shares at $5.90 ($5K) on 2008-03-17, disclosed to the SEC on 2008-03-18.
Open-market purchase of $5k INFI by EVP and Chief Business Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.90 | 426 | $3K | 54.8% |
| 2 | $5.91 | 300 | $2K | 38.7% |
| 3 | $5.93 | 50 | $297 | 6.5% |
| Total | $5.91 avg | 776 | $5K | 100% |
| Filing → |
| INFI | SELL | 2018-03-07 | $14K | — | Filing → |
| INFI | SELL | 2015-06-26 | $55K | — | Filing → |
| INFI | SELL | 2015-05-28 | $128K | — | Filing → |